Search Results for "Alnylam"
Alnylam is committed to providing the healthcare community with balanced, accurate, and high-quality information about our science, therapeutic areas, and products.
More than one search term is recommended to yield the most relevant results. By searching, you confirm that your query is unsolicited.
For more information about our FDA-approved therapies, please see the Full Prescribing Information:
Vutrisiran: Vitamin A Levels
Standard response letter on vutrisiran and vitamin A levels, including information on supplementation.
Standard response letter on vutrisiran and vitamin A levels, including information on supplementation.
Zilebesiran: Phase 1 Study Overview
Standard response letter on the phase 1 study of zilebesiran, a study evaluating the safety, PK , PD, as well as exploratory antihypertensive efficacy of zilebesiran in patients with hypertension.
Standard response letter on the phase 1 study of zilebesiran, a study evaluating the safety, PK , PD, as well as exploratory antihypertensive efficacy of zilebesiran in patients with hypertension.
Vutrisiran: Pharmacokinetic and Pharmacodynamic Properties
Standard Response Letter on vutrisiran and its pharmacokinetic and pharmacodynamic properties.
Standard Response Letter on vutrisiran and its pharmacokinetic and pharmacodynamic properties.
Patisiran: Preparation and Administration
Standard response letter on the preparation and administration of patisiran.
Standard response letter on the preparation and administration of patisiran.
Patisiran: Management of Infusion-Related Reactions
Standard response letter on the management of infusion-related reactions in patisiran clinical studies.
Standard response letter on the management of infusion-related reactions in patisiran clinical studies.
Givosiran: Pregnancy and Lactation
Standard response letter on givosiran and its use in pregnant or lactating patients.
Standard response letter on givosiran and its use in pregnant or lactating patients.
Efficacy and Safety of Vutrisiran and Patisiran
Standard response letter on the efficacy and safety of vutrisiran and patisiran, summarizing data from the HELIOS-A study and the APOLLO study.
Standard response letter on the efficacy and safety of vutrisiran and patisiran, summarizing data from the HELIOS-A study and the APOLLO study.